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Abstract
Introduction: Ralstonia pickettii is an infrequent pathogen of invasive infections in healthy individuals.
The microorganism is supposed to be of relatively low virulence, but can cause infections, mainly of
the respiratory tract, in immunocompromised and cystic fibrosis patients. Ralstonia pickettii has also
been associated with hospital outbreaks related to contamination of products used for medical care
and laboratory diagnosis.
Case presentation: We report here a case of septic arthritis due to Ralstonia pickettii in a female
diabetic patient. The microorganism was identified from the synovial fluid by molecular-based
methods, while the conventional synovial and blood cultures proved to be negative. The patient was
treated by intravenous ceftazidime with complete remission of her symptoms; she was discharged
3 weeks after admission in a very good health. At follow-up examination 3 weeks later, she was still in
good health condition without any sign of arthritis of the right knee and afebrile.
Conclusion: In culture negative serious bacterial infections, as septic arthritis, the use of molecular-
based techniques might be of outmost importance as additional and rapid diagnostic tools for the
identification of the causative agent allowing a prompt and appropriate antimicrobial therapy and a
favourable outcome.
Introduction
Ralstonia pickettii, formerly known as Pseudomonas
(Burkholderia) pickettii, is a non-fermenting gram-negative
bacillus that is found in water, soil, plants, fruits and
vegetables [1]. Infections due to Ralstonia pickettii are very
rare in healthy individuals, since the microorganism is
supposed to be of relatively low virulence and is often
associated with pseudobacteremia or asymptomatic
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colonization of the respiratory tract as, for instance, in
cystic fibrosis patients [2]. However, Ralstonia pickettii
hospital outbreaks have been reported and associated with
extrinsic contamination of disinfectants, saline solution,
sterile water and other solutions used for patient care [3,4].
Herein, we describe a case of septic arthritis caused by
Ralstonia pickettii in a female diabetic patient. Of interest,
the microorganism was identified rapidly and directly
from the clinical sample by molecular techniques, while
the conventional culture methods proved to be negative.
Case presentation
An 83-year-old female Greek patient of Caucasian origin
patient was admitted to the Department of Medicine,
Medical School University of Thessaly, Larissa, Greece
because of fever and severe arthritis of the right knee. Her
past medical history was positive of arterial hypertension,
adult-onset diabetes mellitus and an episode of ischemic
stroke. She was on treatment with amlodipine, moxoni-
dine, valsartan, clopidogrel, atorvastatin and sc insulin.
On admission the patient was febrile (38°C) and was
complaining for pain at the right knee for the last 15 days.
Physical examination revealed warmth, redness and
swelling in the area of the right knee and a harsh systolic
murmur (2-3/6) that was heard along the left sternal
border radiating to the neck. The remaining physical
examination was unremarkable. Blood pressure was
144/88 mmHg, heart rate was 98 beats per min and her
respiratory rate was 16 per min. White blood cell count
(10.5 × 109/L), erythrocyte sedimentation rate (80 mm/
1h), blood glucose (170 mg/dL) and C-reactive protein
(127 mg/dL; upper normal limit: 10 mg/dL) were elevated.
The remaining haematological and biochemical parameters
were within normal limits. Synovial fluid aspiration was
performed by a sterile syringe and the sample was then
immediately transported to the clinical microbiology
laboratory. The fluid was grossly purulent with 35,000/μL
leukocytes (92% polymorphonuclear cells), although no
microorganisms were seen on Gram staining. Light
microscopy of the aspirated material did not show the
presence of any crystals. Empirical intravenous antibiotic
treatment was started with 2 g of ceftriaxone b.i.d. and
500 mg of daptomycin q.d. at this time for septic arthritis.
A trans-thoracic echocardiogram was unrevealing.
An aliquot of synovial fluid was inoculated directly onto
5% sheep blood agar and chocolate agar, which were
incubated at 35°Cwith 5 to 7%CO2 for 7 days; in parallel,
3 ml of the synovial fluid were inoculated into a BACTEC
Peds Plus/F bottle, which was loaded into the BACTEC
9240 instrument and incubated for 7 days. In addition,
total DNA and RNA were extracted from a volume of 2 ml
of synovial fluid. Then, 5 μl of DNA was used as template
for the detection of bacterial DNA, using the 16 S rRNA
PCR assay as we have described previously [5,6]. After
amplification, the PCR product was purified and
sequenced, and the obtained sequences (approximately
460 bp) were compared with the 16S rRNA sequences
available both in the Ribosomal Database Project and the
Genbank and EMBL, obtained from the National Center
for Biotechnology Information Database by the advanced
BLAST search. The viability of the microorganism was
assessed by reverse-transcription of the extracted RNA
(Invitrogen), followed by PCR using the primers described
previously [5,6]. The results showed the presence of
Ralstonia pickettii, while the viability test confirmed that
the microorganism was viable. The results were available
within three days from the date of specimen collection. At
this point the treatment was changed to intravenous
administration of 2 g t.i.d. of ceftazidime as the patient
had not responded to the previous antibiotic regimen.
Intravenous antibiotic treatment with ceftazidime was
continued for 3 weeks. Laboratory inflammatory indices
returned back to normal gradually, the fever disappeared
and no repeated drainage was required as the arthritis
resolved completely. The patient was discharged 3 weeks
after admission in a very good health. At follow-up
examination 3 weeks later, she was still in good health
condition without any sign of arthritis of the right knee
and afebrile. Of note, the conventional synovial fluid
cultures and consecutive blood cultures failed to detect the
microorganism; after a prolonged incubation of fifteen
days no growth of microorganisms was observed.
Conclusion
A few number of reports in the English literature indicate
that Ralstonia pickettiimay be responsible for more invasive
and severe infections than was previously thought. Indeed,
reports on bacteremia and septicemia caused by Ralstonia
pickettii have already been described [7,8]. Occasionally,
Ralstonia pickettii has been identified as the causative agent
in infectious endocarditis [9], meningitis [10], seminal
infection [11], osteomyelitis or spondylodiskitis [12] and
septic arthritis [13]. Immunocompromised patients and
those with cystic fibrosis are also at increased risk of
acquiring infection with Ralstonia pickettii [14,15]. Other
underlying conditions that have been implicated in
Ralstonia pickettii invasive infections include alcoholic
and hepatitis C related cirrhosis, chronic renal failure
and diabetes mellitus [16].
Although Ralstonia pickettii is not a fastidious microorgan-
ism, in our hands the conventional cultures of synovial
fluid and blood samples were negative. The latter could be
attributed to the fact that this microorganism in general, is
characterized by a relatively low inoculum. In addition, it
is well known that conventional cultures may lack the
sensitivity and specificity to establish an aetiologically
definite diagnosis in cases of septic arthritis. It seems that
at least in some cases, broad-range 16 S rRNA PCR assay
Page 2 of 3
(page number not for citation purposes)
Cases Journal 2009, 2:8125 http://casesjournal.com/casesjournal/article/view/8125
followed by sequencing might be of outmost importance
in an attempt to successfully identify microorganisms
involved in such infections like septic arthritis and in
particular, when patients have previously received anti-
biotics or in the presence of slow-growing or intracellular
microorganisms [5,17]. In this context, our findings
further emphasize the potential usefulness of molecular-
based methods as additional and rapid diagnostic tools
for the identification of the causative agent of serious
bacterial infections. Furthermore, the use of a viability test
in case of a positive result by the 16 S rRNA PCR assay gives
an additional advantage of the molecular-based assays as
with this test we are capable to assess whether the causative
microorganism is alive or not. However, the use of
these assays should be rather restricted mainly in culture-
negative cases and when serious infections are suspected
on the basis of clinical signs and symptoms [5].
Abbreviations
sc, Subcutaneous; CO2, Carbon dioxide; DNA, Deoxy-
ribose Nucleic Acid; RNA, Ribose Nucleic Acid; PCR,
Polymerase Chain Reaction; bp, Base Pairs; rRNA,
Ribosomal RNA.
Consent
Written informed consent was obtained from the patient
for publication of this case report. A copy of the written
consent is available for review from the journal’s Editor in
Chief.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
KPM and GND had the original idea and along with NG
wrote the paper. CHN and EP did the whole laboratory
work and investigate the patients’ samples while con-
tributed to the final version of the paper. From the clinical
point of view, KPM, NG and GND collected the whole
data, treated the patient and performed the follow-up
assessment. GND and KPM wrote the final version of the
paper. All authors have seen and approved the final draft
of the paper.
References
1. Gilligan PH, Whittier S: Burkholderia, Stenotrophomonas,
Ralstonia, Brevundimonas, Comamonas, and Acidovorax. In
Manual of clinical microbiology. 7th edition. Edited by Murray PR,
Baron EJ, Pfaller MA, Tenover FC, Yolken RH. Washington DC: ASM
Press; 1999:526-538.
2. Gilligan PH: Microbiology of airway disease in patients with
cystic fibrosis. Clin Microbiol Rev 1991, 4:35-51.
3. Labarca JA, Trick WE, Peterson CL, Carson LA, Holt SC, Arduino MJ,
Meylan M, Mascola L, Jarvis WR: A multistate nosocomial
outbreak of Ralstonia pickettii colonization associated with
an intrinsically contaminated respiratory care solution. Clin
Infect Dis 1999, 29:1281-1286.
4. Roberts LA, Collignon PJ, Cramp VB, Alexander S, McFarlane AE,
Graham E, Fuller A, Sinickas V, Hellyar A: An Australia-wide
epidemic of Pseudomonas pickettii bacteremia due to con-
taminated “sterile” water for injection. Med J Aust 1990,
152:652-655.
5. Petinaki E, Dalekos GN: Molecular methods as tools for the
diagnosis of bacterial infections: useful or useless? Res Adv
Microbiology 2006, 6:23-31.
6. Gatselis N, Malli E, Papadamou G, Petinaki E, Dalekos GN: Direct
detection of Cardiobacterium hominis in serum from a patient
with infective endocarditis by broad-range bacterial PCR.
J Clin Microbiol 2006, 44:669-672.
7. Fujita S, Yoshida T, Matsubara F: Pseudomonas pickettii bacter-
emia. J Clin Microbiol 1981, 13:781-782.
8. Marroni M, Pasticci MB, Pantosti A, Colozza MA, Stagni G, Tonato M:
Outbreak of infusion-related septicemia by Ralstonia pickettii
in the oncology department. Tumori 2003, 89:575-576.
9. Graber CD, Jervey LP, Ostrander WE, Salley LH, Weaver RE:
Endocarditis due to a lanthanic, unclassified Gram-negative
bacterium (group IV d). Am J Clin Pathol 1968, 49:220-223.
10. Heagney MA: An unusual case of bacterial meningitis caused by
Burkholderia pickettii. Clin Microbiol News 1998, 20:102-103.
11. Carrell DT, Emery BR, Hamilton B: Seminal infection with
Ralstonia pickettii and cytolysosomal spermophagy in a
previously fertile man. Fertil Steril 2003, 79:1665-1667.
12. Sudo H, Hisada Y, Ito M, Kotaki H, Minami A: Burkholderia
pickettii spondylitis. Spinal Cord 2005, 43:499-502.
13. Zellweger C, Bodmer T, Täuber MG, Mühlemann K: Failure of
ceftriaxone in an intravenous drug user with invasive
infection due to Ralstonia pickettii. Infection 2004, 32:246-248.
14. Coenye T, Vandamme P, LiPua JJ: Infections by Ralstonia species
in cystic fibrosis patients: identification of R. Pickettii and R.
mannitolilytica by polymerase chain reaction. Emerg Infect Dis
2002, 8:692-696.
15. Stelzmueller I, Biebl M, Wiesmayr S, Eller M, Hoeller E, Fille M,
Weiss G, Lass-Floerl C, Bonatti H: Ralstonia pickettii-innocent
bystander or a potential threat? Clin Microbiol Infect 2006,
12:99-101.
16. Ryan MP, Pembroke JT, Adley CC: Ralstonia pickettii: a persistent
Gram-negative nosocomial infectious organism. J Hosp Infect
2006, 62:278-284.
17. Fenollar F, Lévy PY, Raoult D: Usefulness of broad-range PCR for
the diagnosis of osteoarticular infections. Curr Opin Rheumatol
2008, 20:463-470.
Page 3 of 3
(page number not for citation purposes)
Cases Journal 2009, 2:8125 http://casesjournal.com/casesjournal/article/view/8125
Do you have a case to share?
Submit your case report today
• Rapid peer review
• Fast publication
• PubMed indexing
• Inclusion in Cases Database
Any patient, any case, can teach us
something
www.casesnetwork.com
